Traders should monitor for continued insider selling, especially given the 10b5-1 plan execution and recent volume. While prearranged, the scale and timing—amid a $3.6B market cap—may signal reduced confidence, particularly if not offset by fundamentals in upcoming earnings.
Price Chart
Executive Summary
Roger Jeffs, a director and officer of Liquidia Corp, filed a Form 144 to report proposed sales of 148,277 shares through Serendipity Biopharma LLC and personal transactions, with recent sales totaling approximately $4.0 million over five days in mid-April 2026. The sales are conducted under a 10b5-1 plan, indicating prearranged trading, but come amid elevated insider selling activity.
Key Facts
- Roger Jeffs, Director and Officer of Liquidia Corp, is the reporting owner.
- Form 144 filed for 148,277 common shares, with recent sales executed between April 9–17, 2026.
- Total value of reported transactions: ~$4.01 million (sum of $1,007,800 + $1,003,522.50 + $132,000 + $1,256,387.28 + $859,876.96 + $1,002,887.50).
- Sales conducted under a 10b5-1 plan for Serendipity Biopharma LLC, suggesting pre-planned disposition.
- Recent insider activity shows 6 sell transactions in the past 30 days totaling $3.9M, indicating sustained insider selling pressure.
Financial Impact
$4.01 million in proposed and recently executed sales by a corporate insider
Risk Factors
- Perception of insider pessimism despite 10b5-1 plan justification
- Increased selling pressure from affiliates could weigh on share price
- Lack of offsetting insider buying or positive corporate news
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003618 |
| Document: 0001950047-26-003618-index.html | 0001950047-26-003618 |
| Document: 0001950047-26-003618.txt | 0001950047-26-003618 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 12d ago | 8-K | $33.94 $34.78 | ▲ +2.48% | ▲ +2.19% | $43.74 (+28.87%) |
Oct 13, 2026 12d ago | Insider Cluster | $33.94 $34.78 | ▲ +2.48% | ▲ +2.19% | $43.74 (+28.87%) |
Sep 30, 2026 25d ago | 8-K | $27.99 $28.64 | ▼ −2.32% | ▼ −1.58% | $43.74 (−56.27%) |
Sep 3, 2026 7w ago | 8-K | $68.63 $68.66 | ▲ +0.04% | ▲ +0.43% | $43.74 (−36.27%) |
Sep 3, 2026 7w ago | Press Release | $68.63 $68.66 | ▲ +0.04% | ▲ +0.43% | $43.74 (−36.27%) |
Aug 25, 2026 8w ago | Insider Cluster | $71.36 $69.94 | ▼ −1.99% | ▼ −2.65% | $43.74 (−38.71%) |
Aug 21, 2026 9w ago | Insider Cluster | $70.27 $70.49 | ▲ +0.31% | ▼ −0.01% | $43.74 (−37.75%) |
Aug 12, 2026 10w ago | 8-K | $78.79 $72.10 | ▼ −8.49% | ▼ −9.19% | $43.74 (−44.49%) |
Aug 12, 2026 10w ago | Press Release | $78.79 $72.10 | ▲ +8.49% | ▲ +9.19% | $43.74 (+44.49%) |
Jul 29, 2026 12w ago | Insider Cluster | $86.80 $84.11 | ▼ −3.10% | ▼ −3.82% | $43.74 (−49.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers